Edition:
India

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

218.50EUR
20 Oct 2020
Change (% chg)

€3.00 (+1.39%)
Prev Close
€215.50
Open
€215.50
Day's High
€220.00
Day's Low
€213.50
Volume
5,971
Avg. Vol
5,623
52-wk High
€250.00
52-wk Low
€132.20

Latest Key Developments (Source: Significant Developments)

BRIEF-Virbac Sees Decline In 2020 Revenue Of Between 3%-0%
Monday, 20 Jul 2020 

Repeats with no change.:Q2 REVENUE EUR 230.6 MILLION, DOWN -6.4% COMPARED TO SAME PERIOD IN 2019.ANIMAL HEALTH SECTOR HELPED TO LIMIT IMPACT ON BUSINESS AT END-JUNE, DESPITE ANTICIPATED DOWNTURN IN Q2 2020.STILL MANY UNKNOWNS REGARDING OUTLOOK FOR DEMAND IN COUNTRIES IN WHICH WE OPERATE (PARTICULARLY IN MAJOR COUNTRIES: UNITED STATES, INDIA, AND CHILE).COVID-19: ON SUPPLY SIDE, WE MANAGED TO LIMIT IMPACT ON H1.H1 REVENUE EUR 478.3 MILLION VERSUS EUR 463.7 MILLION YEAR AGO.ANTICIPATES DECLINE IN REVENUE OF BETWEEN -3% AND 0% FOR 2020 AT ACTUAL SCOPE (AFTER DISPOSAL OF SENTINEL) AND AT CONSTANT EXCHANGE RATES.DISPOSAL OF SENTINEL BRANDS EARLY JULY AND DECREASE IN THE RATIO EBITA TO REVENUE OF AROUND 3 POINTS ON PRO FORMA FULL-YEAR BASIS.DISPOSAL OF SENTINEL BRANDS EARLY JULY EXPECTED TO RESULT IN DECREASE IN REVENUE OF ABOUT US$55 MILLION.ON BASIS OF CURRENT EXCHANGE RATES, ANTICIPATES UNFAVORABLE EXCHANGE RATE IMPACT ON REVENUE OF AROUND €25 TO €30 MILLION RELATED TO SHARP DEPRECIATION OF CURRENCIES IN LATIN AMERICA AND ASIA-PACIFIC.IMPACT ON THE EBITA TO REVENUE RATIO SHOULD BE LIMITED TO AROUND 1 POINT IN 2020, GIVEN THE GOOD LEVEL OF SALES FROM SENTINEL, WHICH REPRESENTED SALES OF US$39 MILLION IN THE FIRST HALF.  Full Article

Virbac FY Revenue Up At 938.2 Million Euros
Thursday, 16 Jan 2020 

Jan 16 (Reuters) - VIRBAC SA ::FY REVENUE FROM ORDINARY ACTIVITIES OF EUR 938.2 MILLION VERSUS EUR 868.9 MILLION YEAR AGO.IN 2019, RATIO OF "CURRENT OPERATING PROFIT BEFORE DEPRECIATION OF ASSETS ARISING FROM ACQUISITIONS" TO "REVENUE", IS EXPECTED TO INCREASE BY AROUND 3 POINTS AT CONSTANT EXCHANGE RATES COMPARED TO 2018.FROM FINANCIAL PERSPECTIVE, RIGOROUS CONTROL OF CAPITAL EMPLOYED SHOULD ALLOW FURTHER DEBT RELIEF OF ABOUT EUR 80 MILLION AT CONSTANT RATES FOR YEAR.FOR 2020, GROUP ANTICIPATES REVENUE GROWTH AT CONSTANT RATES OF BETWEEN 4% AND 6%.FOR 2020, EXPECTS INCREASE IN RATIO OF "CURRENT OPERATING PROFIT BEFORE DEPRECIATION OF ASSETS ARISING FROM ACQUISITIONS" TO "REVENUE", OF AROUND 0.5 POINT AT CONSTANT EXCHANGE RATES COMPARED TO 2019.  Full Article

Virbac H1 Operating Profit Up At EUR 50.0 Mln
Monday, 16 Sep 2019 

Sept 16 (Reuters) - Virbac SA ::H1 REVENUE EUR 463.7 MILLION VERSUS EUR 430.0 MILLION YEAR AGO.H1 OPERATING PROFIT EUR 50.0 MILLION VERSUS EUR 36.4 MILLION YEAR AGO.H1 NET PROFIT GROUP SHARE EUR 26.4 MILLION VERSUS EUR 12.3 MILLION YEAR AGO.FIRST HALF-YEAR ACTIVITY SUPPORTS OUTLOOK ANNOUNCED BY GROUP FOR 2019..  Full Article

Euronext Announces Quarterly Revision Of French Indices
Friday, 13 Sep 2019 

Sept 13 (Reuters) - EURONEXT NV ::ANNOUNCED ON THURSDAY QUARTERLY REVIEW OF THE CAC FAMILY INDICES.THERE ARE NO CHANGES TO THE CAC 40 INDEX <<<.FCHI>>>.VIRBAC TO BE INCLUDED IN THE SBF 120 INDEX <<<.SBF120>>> AND CAC MID 60 INDEX <<<.CACMD>>>.TECHNICOLOR TO BE REMOVED FROM THE SBF 120 INDEX AND CAC MID 60 INDEX.CHANGES WILL BE EFFECTIVE AS OF SEPT. 23.  Full Article

Virbac Q1 Revenue Up At 217.5 Million Euros
Thursday, 11 Apr 2019 

April 11 (Reuters) - VIRBAC SA ::REG-VIRBAC : 2019 FIRST QUARTER REVENUE ROSE BY +10.9% AT COMPARABLE EXCHANGE RATES.REVENUE REACHED EUR 217.5 MILLION IN Q1, AN INCREASE OF +12.4%.PREDICTS WILL BE STRONG IN ALL OTHER REGIONS, REVENUE AT CONSTANT RATES IS EXPECTED TO RISE FROM 4% TO 6% IN 2019 COMPARED WITH 2018.FOR FY 2019 SEES RATIO OF “OPERATING PROFIT FROM ORDINARY ACTIVITIES BEFORE DEPRECIATION OF ASSETS ARISING FROM ACQUISITIONS” TO “REVENUE” TO INCREASE BY AROUND 1 POINT COMPARED TO 2018 AT CONSTANT EXCHANGE RATES.TIGHT CONTROL OF INVESTED CAPITAL SHOULD ALLOW FURTHER DEBT RELIEF, WHICH IS EXPECTED TO HOVER AROUND €30 MILLION, AT CONSTANT RATES, FOR THE YEAR.  Full Article

Virbac FY Operating Profit Up At 65.0 Million Euros
Monday, 18 Mar 2019 

March 18 (Reuters) - VIRBAC SA ::REG-VIRBAC: 2018 OPERATING PROFIT FROM ORDINARY ACTIVITIES GREW BY 13.4%.REVENUE AT CONSTANT RATES IS EXPECTED TO RISE FROM 4% TO 6% IN 2019 COMPARED WITH 2018.FY NET PROFIT GROUP SHARE EUR 20.1 MILLION VERSUS LOSS OF EUR 2.6 MILLION YEAR AGO.FY OPERATING PROFIT EUR 65.0 MILLION VERSUS EUR 58.0 MILLION YEAR AGO.REVENUE AT CONSTANT RATES IS EXPECTED TO RISE FROM 4% TO 6% IN 2019 COMPARED WITH 2018.FOR 2019 ANTICIPATES THE RATIO OF “OPERATING PROFIT FROM ORDINARY ACTIVITIES BEFORE DEPRECIATION OF ASSETS ARISING FROM ACQUISITIONS” TO “REVENUE” TO INCREASE BY AROUND 1 POINT AT CONSTANT EXCHANGE RATES COMPARED TO 2018.FY OPERATING CASH FLOW BEFORE INTEREST AND TAXES EUR 119.3 MILLION VERSUS EUR 107.0 MILLION YEAR AGO.FY REVENUE FROM ORDINARY ACTIVITIES EUR 868.9 MILLION VERSUS EUR 861.9 MILLION YEAR AGO.  Full Article

Virbac Annual Revenue Increases to 234.5 Million Euros
Thursday, 17 Jan 2019 

Jan 17 (Reuters) - VIRBAC SA ::REG-VIRBAC : 2018 ANNUAL REVENUE GREW BY +4.5% AT CONSTANT EXCHANGE RATES.GROUP REVENUE REACHED EUR 234.5 MILLION IN Q4, AN INCREASE OF +1.2% AT REAL RATES.FOR 2018, GROUP ANTICIPATES RATIO OF CURRENT OPERATING PROFIT BEFORE DEPRECIATION OF ASSETS ARISING FROM ACQUISITIONS TO REVENUE, SHOULD INCREASE, AS EXPECTED, BY AROUND 1 POINT AT CONSTANT EXCHANGE RATES COMPARED TO 2017.FOR 2018 GROUP'S NET DEBT TO EBITDA RATIO IS EXPECTED TO BE BELOW FINANCIAL COVENANT OF 4.25 AT END OF DECEMBER 2018, AS NEGOTIATED WITH GROUP'S BANKING PARTNERS.  Full Article

BRIEF-Virbac To Assign US Rights Of SENTINEL® Trademarks To MSD Sante Animale

* READY TO ASSIGN US RIGHTS TO THE SENTINEL® TRADEMARKS TO MSD SANTE ANIMALE